scispace - formally typeset
Search or ask a question

Showing papers by "Robert H. Bartlett published in 1989"


Journal ArticleDOI
TL;DR: Electracorporeal Membrane Oxygenation appears to be a successful, reliable, and safe method of respiratory support for selected, critically ill infants with CDH.
Abstract: Extracorporeal Membrane Oxygenation (ECMO) has been available to neonates with respiratory failure at the University of Michigan School of Medicine since June 1981. In order to evaluate the impact of this type of pulmonary support, a retrospective analysis of 50 neonates with posterolateral congenital diaphragmatic hernia (CDH) who were symptomatic during the first hour of life and were treated between June 1974 and December 1987 was carried out. The patients were divided into two groups, those treated before June 1981 (16 patients) and those treated after June 1981 (34 patients). Overall survival improved from 50% (eight of 16 patients) during the pre-ECMO era to 76% (26 of 34 patients) during the post-ECMO period (p = 0.06). During the period after June 1981, 21 neonates were unresponsive to conventional therapy and were therefore considered for ECMO. Failure of conventional therapy was defined as acute clinical deterioration with an expected mortality of greater than 80% based on an objective formula previously reported. Six patients were excluded on the basis of specific contraindications to ECMO. Thirteen of 15 infants (87%) supported with ECMO survived. Three patients treated before 1981 met criteria for ECMO; all three died while receiving treatment using conventional therapy. These survival differences are significant (p less than 0.01). In addition, the survival of 87% for the infants treated with ECMO versus the expected mortality of greater than 80% for these same patients when treated with conventional therapy is highly significant (p less than 0.005). Based on this data, ECMO appears to be a successful, reliable, and safe method of respiratory support for selected, critically ill infants with CDH.

116 citations


Journal ArticleDOI
TL;DR: This catheter was designed for single site cannulation of the internal jugular vein, thereby sparing the carotid artery from ligation, and can replace venoarterial access in most cases of neonatal respiratory failure.
Abstract: After satisfactory development and testing of a polyurethane 14 Fr double lumen catheter, we used this device for venovenous extracorporeal life support in neonates who had respiratory failure. This catheter was designed for single site cannulation of the internal jugular vein, thereby sparing the carotid artery from ligation. Cannulation was successful in 17 of 21 neonates, with 15 successful venovenous runs, whereas 2 of the 17 patients were converted to venoarterial bypass because of inadequate support. Oxygenation and CO2 removal were adequate in the remaining patients. Average time on bypass was 111 hours. All 15 patients survived, and exploration of the cannulation site for bleeding was required in three patients. Preoxygenator pressure, recirculation of oxygenated blood, and hemolysis were all within acceptable levels during each run. Venovenous extracorporeal life support with the double lumen catheter can replace venoarterial access in most cases of neonatal respiratory failure.

74 citations


Journal ArticleDOI
TL;DR: The authors designed and tested a 14F outside diameter thin-walled double lumen catheter for neonatal venovenous (VV) extracorporeal membrane oxygenation (ECMO) and found this catheter is well suited for clinical VV ECMO in neonates.
Abstract: The authors designed and tested a 14F outside diameter thin-walled double lumen catheter (DLC) for neonatal venovenous (VV) extracorporeal membrane oxygenation (ECMO) In vitro tests with water and dye solution showed capacity of the drainage lumen was 1,096 ml/min at 100 cm siphon, and pressure drop across the perfusion lumen was 300 mmHg at 500 ml/min flow Recirculation at 500 ml/min flow ranged from 5 to 29%, depending upon simulated cardiac output The highest serum hemoglobin during 12 hour 400 ml/min flow VV bypass in five dogs was 49 mg/dl Typical oxygen transport in four dogs was 25 cc/min at 400 ml/min flow This catheter is well suited for clinical VV ECMO in neonates

31 citations


Journal ArticleDOI
TL;DR: This experiment investigated the relationship between oxygen consumption and oxygen delivery (cardiac output X arterial oxygen content) in an acute canine model and found that oxygen consumption was constant and independent of oxygen delivery at oxygen delivery levels greater than 8.0 cc/kg/min.

25 citations


Journal Article
TL;DR: Although the vocal cord paralysis resolved in all cases, two patients had difficult courses after extracorporeal membrane oxygenation, therefore, laryngoscopic examination should be considered for patients after extacorporeal membranes oxygenation.
Abstract: Five cases of unilateral vocal cord paralysis/ paresis were diagnosed following extracorporeal membrane oxygenation for newborn respiratory failure. All were right sided and transient in nature. None of the five patients had other findings commonly associated with vocal cord palsy. The extracorporeal membrane oxygenation procedure requires surgical dissection in the carotid sheath on the right side of the neck, an area immediately adjacent to both the vagus and recurrent laryngeal nerve. It is speculated that vocal cord paralysis in these infants was acquired as a result of the extracorporeal membrane oxygenation cannulation. Although the vocal cord paralysis resolved in all cases, two patients had difficult courses after extracorporeal membrane oxygenation. Therefore, laryngoscopic examination should be considered for patients after extracorporeal membrane oxygenation.

20 citations